Correction: Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction: Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials ; day:5 ; month:1 ; year:2024 ; pages:1
Prevention science ; (5.1.2024), 1
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11121-023-01615-0
- URN
-
urn:nbn:de:101:1-2024031821301059074817
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Xueqi
- Goldfeld, Keith S.
- Taljaard, Monica
- Li, Fan
- SpringerLink (Online service)
Other Objects (12)
Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials
Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors
Correction: Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors
Sample size requirements for pilot randomised controlled trials with continuous outcomes: a simulation study
Sample size requirements for pilot randomised controlled trials with binary outcomes: a simulation study
Bayesian evaluation of informative hypotheses in cluster-randomized trials
Impact of Different Visual Field Testing Paradigms on Sample Size Requirements for Glaucoma Clinical Trials
Methods for subgroup selection in biomarker-based clinical trials
Sample size requirements for fractal dimension estimation
Risk stratification in clinical trials: a subgroup to be encouraged
Anemia and adverse outcomes in pregnancy: subgroup analysis of the CLIP cluster-randomized trial in India
Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study
Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials
Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors
Correction: Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors
Sample size requirements for pilot randomised controlled trials with continuous outcomes: a simulation study
Sample size requirements for pilot randomised controlled trials with binary outcomes: a simulation study
Bayesian evaluation of informative hypotheses in cluster-randomized trials
Impact of Different Visual Field Testing Paradigms on Sample Size Requirements for Glaucoma Clinical Trials
Methods for subgroup selection in biomarker-based clinical trials
Sample size requirements for fractal dimension estimation
Risk stratification in clinical trials: a subgroup to be encouraged
Anemia and adverse outcomes in pregnancy: subgroup analysis of the CLIP cluster-randomized trial in India
Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study
Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials
Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors
Correction: Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors
Sample size requirements for pilot randomised controlled trials with continuous outcomes: a simulation study
Sample size requirements for pilot randomised controlled trials with binary outcomes: a simulation study
Bayesian evaluation of informative hypotheses in cluster-randomized trials
Impact of Different Visual Field Testing Paradigms on Sample Size Requirements for Glaucoma Clinical Trials
Methods for subgroup selection in biomarker-based clinical trials
Sample size requirements for fractal dimension estimation
Risk stratification in clinical trials: a subgroup to be encouraged
Anemia and adverse outcomes in pregnancy: subgroup analysis of the CLIP cluster-randomized trial in India